B02BD03 • coagulation anti-inhibitor complex • Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
The coagulation anti-inhibitor complex is used for the treatment of bleeding episodes in patients with hemophilia A or B who have inhibitors to coagulation factors VIII or IX. It works by providing coagulation factors that bypass the inhibitors, promoting blood clot formation.
The medication is administered intravenously, as directed by a doctor, usually during bleeding episodes or before surgical procedures. It is important for patients to follow the recommended dosage and be monitored for treatment effectiveness.
Patients should be aware of potential side effects, such as allergic reactions, fever, or thrombosis. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, fever, and nausea. In rare cases, severe reactions such as thrombosis or anaphylactic reactions may occur. Patients should be informed of these risks before use.
Substance: coagulation anti-inhibitor complex
Date of last drug list: 01-04-2026
Commercial code: W62498002
Concentration: 25U / ml
Pharmaceutical form: powder+solvent for solution for infusion
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: BAXTER AG - AUSTRIA
Holder: BAXALTA INNOVATIONS GMBH - AUSTRIA
Number: 11224/2018/02
Shelf life: 2 years